READ-ONLY DIGITIZATION RESULT
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial.
JAMA Oncol · 2026-Feb-01 · PMID 41343176
Panel B质量警告待 EXE 对齐验证
Disease-Free Survival
Figure 3. Disease-Free Survival (DFS) by Celecoxib vs. Placebo and Circulating Tumor DNA (ctDNA) Status Among Select Subgroups of Interest. [A] Non-MSI-High [B] MSI-High [C] PIK3CA Wildtype [D] PIK3CA Mutant Disease free survival, stratified by assigned oral agent (celecoxib or placebo) and postoperative ctDNA status in 2×2 fashion. Shown are subgroups of patients with A: non-microsatellite instability high tumors (non-MSI-High), B: microsatellite instability high tumors (MSI-High), C: PIK3CA wildtype tumors, and D: PIK3CA mutant tumors. Data cutoff was 6 years after time of randomization.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.9622 | 0.0000 | 86.6000 | 169 | 42 |
| 1 | 2 | 0.5130 | 0.9622 | 2.5651 | 86.6000 | 484 | 42 |
| 1 | 3 | 0.5147 | 0.9622 | 2.5733 | 86.6000 | 485 | 42 |
| 1 | 4 | 0.5163 | 0.9622 | 2.5814 | 86.6000 | 486 | 42 |
| 1 | 5 | 0.5179 | 0.9622 | 2.5896 | 86.6000 | 487 | 42 |
| 1 | 6 | 0.5195 | 0.9622 | 2.5977 | 86.6000 | 488 | 42 |
| 1 | 7 | 0.5212 | 0.9622 | 2.6059 | 86.6000 | 489 | 42 |
| 1 | 8 | 0.5228 | 0.9622 | 2.6140 | 86.6000 | 490 | 42 |
| 1 | 9 | 0.5244 | 0.9622 | 2.6221 | 86.6000 | 491 | 42 |
| 1 | 10 | 0.5261 | 0.9622 | 2.6303 | 86.6000 | 492 | 42 |
| 1 | 11 | 0.5277 | 0.9622 | 2.6384 | 86.6000 | 493 | 42 |
| 1 | 12 | 0.5293 | 0.9622 | 2.6466 | 86.6000 | 494 | 42 |
| 1 | 13 | 0.5309 | 0.9622 | 2.6547 | 86.6000 | 495 | 42 |
| 1 | 14 | 0.5326 | 0.9622 | 2.6629 | 86.6000 | 496 | 42 |
| 1 | 15 | 0.5342 | 0.9622 | 2.6710 | 86.6000 | 497 | 42 |
| 1 | 16 | 0.5358 | 0.9622 | 2.6792 | 86.6000 | 498 | 42 |
| 1 | 17 | 0.5375 | 0.9622 | 2.6873 | 86.6000 | 499 | 42 |
| 1 | 18 | 0.5391 | 0.9622 | 2.6954 | 86.6000 | 500 | 42 |
| 1 | 19 | 0.5407 | 0.9622 | 2.7036 | 86.6000 | 501 | 42 |
| 1 | 20 | 0.5423 | 0.9622 | 2.7117 | 86.6000 | 502 | 42 |
| 1 | 21 | 0.5440 | 0.9622 | 2.7199 | 86.6000 | 503 | 42 |
| 1 | 22 | 0.5456 | 0.9622 | 2.7280 | 86.6000 | 504 | 42 |
| 1 | 23 | 0.5472 | 0.9622 | 2.7362 | 86.6000 | 505 | 42 |
| 1 | 24 | 0.5489 | 0.9622 | 2.7443 | 86.6000 | 506 | 42 |
| 1 | 25 | 0.5505 | 0.9622 | 2.7524 | 86.6000 | 507 | 42 |
| 1 | 26 | 0.5521 | 0.9622 | 2.7606 | 86.6000 | 508 | 42 |
| 1 | 27 | 0.5537 | 0.9622 | 2.7687 | 86.6000 | 509 | 42 |
| 1 | 28 | 0.5554 | 0.9622 | 2.7769 | 86.6000 | 510 | 42 |
| 1 | 29 | 0.5570 | 0.9622 | 2.7850 | 86.6000 | 511 | 42 |
| 1 | 30 | 0.5586 | 0.9622 | 2.7932 | 86.6000 | 512 | 42 |
| 1 | 31 | 0.5603 | 0.9622 | 2.8013 | 86.6000 | 513 | 42 |
| 1 | 32 | 0.5619 | 0.9622 | 2.8094 | 86.6000 | 514 | 42 |
| 1 | 33 | 0.5635 | 0.9622 | 2.8176 | 86.6000 | 515 | 42 |
| 1 | 34 | 0.5651 | 0.9622 | 2.8257 | 86.6000 | 516 | 42 |
| 1 | 35 | 0.5668 | 0.9622 | 2.8339 | 86.6000 | 517 | 42 |
| 1 | 36 | 0.5684 | 0.9622 | 2.8420 | 86.6000 | 518 | 42 |
| 1 | 37 | 0.5700 | 0.9622 | 2.8502 | 86.6000 | 519 | 42 |
| 1 | 38 | 0.5717 | 0.9622 | 2.8583 | 86.6000 | 520 | 42 |
| 1 | 39 | 0.5733 | 0.9622 | 2.8664 | 86.6000 | 521 | 42 |
| 2 | 1 | 0.0000 | 0.9622 | 0.0000 | 86.6000 | 169 | 42 |
| 2 | 2 | 0.5130 | 0.9622 | 2.5651 | 86.6000 | 484 | 42 |
| 2 | 3 | 0.5651 | 0.9489 | 2.8257 | 85.4000 | 516 | 48 |
| 2 | 4 | 0.5668 | 0.9489 | 2.8339 | 85.4000 | 517 | 48 |
| 2 | 5 | 0.5684 | 0.9489 | 2.8420 | 85.4000 | 518 | 48 |
| 2 | 6 | 0.5700 | 0.9489 | 2.8502 | 85.4000 | 519 | 48 |
| 2 | 7 | 0.5717 | 0.9489 | 2.8583 | 85.4000 | 520 | 48 |
| 2 | 8 | 0.5733 | 0.9489 | 2.8664 | 85.4000 | 521 | 48 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 2 | 2026-07-24T15:14:58+00:00 |